A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma

导出原文传递

翻译打印收藏纠错

作者： Abramson, Jeremy S. ^[1] ; Redd, Robert A. ^[2] ; Barnes, Jeffrey A. ^[3] ; Bengtson, Elizabeth ^[4] ; Takvorian, Ronald W. ^[5] ; Sokol, Lubomir ^[6] ; Lansigan, Frederick ^[7] ; Armand, Philippe ; Shah, Bijal D. ; Jacobsen, Eric D. ; Neuberg, Donna S. ; LaCasce, Ann S. ; Bello, Celeste M.

作者单位： Dana Farber Canc Inst, Boston, MA 02115 USA ^[1] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA ^[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA ^[3] Massachusetts Gen Hosp, Ctr Canc, Ctr Lymphoma, Boston, MA USA ^[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA ^[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA ^[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA ^[7]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交